Researchers at the University of California are recruiting participants for a first-of-its-kind study of essential tremor and the efficacy of cannabidiol and THC, according to a registered clinical trial.
The Tilray-sponsored research is testing a oral capsule that contains the two cannabinoids.
Researchers are aiming to complete the first phase of the double-blind, placebo-controlled trial by the end of 2020.
They say patients with essential tremor have long reported the benefits of cannabis or this condition, but no controlled trials have been conducted (until now).
Tilray previously announced approval from the DEA to import a medical cannabis product into the United States from Canada for “a clinical trial.”
Essential tremor affects up to 1% of the population and up to 5% of people over the age of 65. The tremor most often affect the hands, head, voice and legs.
The International Essential Tremor Foundation is also supporting the study.